Medicare Enrolled

Dr. Christine Hatch, M.S.R.N., C.S., N.P.

Nurse Practitioner - Primary Care · Newburyport, MA
Low-engagement
21 HIGHLAND AVE, Newburyport, MA 01950
9784621555
In practice since 2007 (19 years)
NPI: 1831304138 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hatch from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hatch? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hatch

Dr. Christine Hatch is a nurse practitioner - primary care in Newburyport, MA, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Hatch received a total of $11,128 from 61 pharmaceutical and/or device companies across 679 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - primary care. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hatch is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $11,128 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$11,128
Total received (2021-2024)
Avg $2,782/year across 4 years
Top 1% in MA for nurse practitioner - primary care
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
679
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,983 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$145 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,279
2023
$3,319
2022
$2,336
2021
$3,195

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$410
Corium, LLC
$187
Boehringer Ingelheim Pharmaceuticals, Inc.
$156
Otsuka America Pharmaceutical, Inc.
$144
Novo Nordisk Inc
$125
Sumitomo Pharma America, Inc.
$117
AstraZeneca Pharmaceuticals LP
$100
Lundbeck LLC
$99
PFIZER INC.
$94
Amgen Inc.
$90
Axsome Therapeutics, Inc.
$78
E.R. Squibb & Sons, L.L.C.
$77
Novartis Pharmaceuticals Corporation
$62
Antares Pharma, Inc.
$59
SHIELD THERAPEUTICS INC
$53
Abbott Laboratories
$51
Merck Sharp & Dohme LLC
$42
Lilly USA, LLC
$42
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$40
Janssen Pharmaceuticals, Inc
$34
Tolmar, Inc.
$32
GlaxoSmithKline, LLC.
$29
Phathom Pharmaceuticals, Inc.
$29
Kyowa Kirin, Inc.
$29
BioCryst US Sales Co., LLC
$28
Exact Sciences Corporation
$26
Seqirus USA Inc
$19
Acella Pharmaceuticals, LLC
$15
Mylan Specialty L.P.
$14
Top 3 companies account for 33.0% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$1,937
AbbVie Inc.
$675
AstraZeneca Pharmaceuticals LP
$621
Novo Nordisk Inc
$594
GlaxoSmithKline, LLC.
$589
Lilly USA, LLC
$535
PFIZER INC.
$496
Lundbeck LLC
$463
Astellas Pharma US Inc
$421
Boehringer Ingelheim Pharmaceuticals, Inc.
$395
Takeda Pharmaceuticals U.S.A., Inc.
$388
Corium, LLC
$374
Janssen Pharmaceuticals, Inc
$343
Novartis Pharmaceuticals Corporation
$334
Sumitomo Pharma America, Inc.
$294
Amgen Inc.
$288
Otsuka America Pharmaceutical, Inc.
$218
Sunovion Pharmaceuticals Inc.
$207
E.R. Squibb & Sons, L.L.C.
$198
IDORSIA PHARMACEUTICALS US INC
$153
Exact Sciences Corporation
$104
Abbott Laboratories
$91
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$86
Teva Pharmaceuticals USA, Inc.
$78
Axsome Therapeutics, Inc.
$78
Esperion Therapeutics, Inc.
$70
SANOFI-AVENTIS U.S. LLC
$67
Merck Sharp & Dohme LLC
$61
ITI, Inc.
$59
Antares Pharma, Inc.
$59
Biohaven Pharmaceuticals, Inc.
$56
SHIELD THERAPEUTICS INC
$53
Biohaven Pharmaceutical Holding Company Ltd.
$49
Tolmar, Inc.
$45
Collegium Pharmaceutical, Inc.
$41
Merck Sharp & Dohme Corporation
$40
Lucid Diagnostics Inc.
$39
Endo Pharmaceuticals Inc.
$37
Kowa Pharmaceuticals America, Inc.
$32
Mylan Specialty L.P.
$29
Phathom Pharmaceuticals, Inc.
$29
Kyowa Kirin, Inc.
$29
Acella Pharmaceuticals, LLC
$28
BioCryst US Sales Co., LLC
$28
Amarin Pharma Inc.
$26
Xeris Pharmaceuticals, Inc.
$23
Boston Scientific Corporation
$22
Insmed, Inc.
$21
Shield Therapeutics Inc
$21
Avanir Pharmaceuticals, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Seqirus USA Inc
$19
Eisai Inc.
$18
Biogen, Inc.
$18
Genentech USA, Inc.
$17
JAZZ PHARMACEUTICALS INC.
$17
Daiichi Sankyo Inc.
$16
Supernus Pharmaceuticals, Inc.
$16
Almatica Pharma LLC
$15
Medtronic, Inc.
$14
Horizon Therapeutics plc
$14
Top 3 companies account for 29.1% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACCRUFER · ADUHELM · AJOVY · ANORO ELLIPTA · ARALAST · AVEED · AZSTARYS · Aimovig · Arikayce · Auvelity · Azstarys · BELSOMRA · BOTOX · BREZTRI · BRINTELLIX · CAPLYTA · CLOSUREFAST · COMIRNATY · COSENTYX · CREON · CUVITRU · Cologuard Collection Kit · Crysvita · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Flucelvax · GARDASIL · GARDASIL 9 · GEMTESA · GVOKE HYPOPEN · INJECTAFER · JARDIANCE · JATENZO · JYNARQUE · KRYSTEXXA · Kerendia · LATUDA · LEQVIO · LINZESS · LOKELMA · MOUNJARO · MYRBETRIQ · Myrbetriq · NAPRELAN · NETSPOT · NEXLETOL · NP Thyroid 60 · NUEDEXTA · NURTEC ODT · OFEV · ORLADEYO · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREMARIN · PREVNAR 13 · PREVNAR 20 · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Rybelsus · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · SUNOSI · SYNJARDY · SYNTHROID · Seglentis · Superion Indirect Decompression System · TLANDO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · UBRELVY · VOQUEZNA · VRAYLAR · VYEPTI · VYNDAQEL · VYVANSE · Vascepa · Veozah · XARELTO · XIFAXAN · XTAMPZA · XYOSTED · Xofluza · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - primary care in MA.

Looking for a nurse practitioner - primary care in Newburyport?
Compare nurse practitioner - primary cares in the Newburyport area by procedure volume, costs, and industry payment transparency.
Browse nurse practitioner - primary cares nearby

Geographic Context

Nurse practitioner - primary cares within 10 mi
56
Per 100K population
6.9
County median income
$99,431
Nearest hospital
ANNA JAQUES HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hatch is a nurse practitioner - primary care, with low-engagement industry engagement in the top 1% of MA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Hatch receive payments from pharmaceutical companies?
Yes. Dr. Hatch received a total of $11,128 from 61 companies across 679 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Hatch) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Nurse Practitioner - Primary Cares in Newburyport
Browse nurse practitioner - primary cares in Newburyport ranked by procedure volume and transparency data.
Highest volume
Top Nurse Practitioner - Primary Cares in MA
Nurse practitioner - primary cares ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nurse Practitioner - Primary Cares in MA
Which MA nurse practitioner - primary cares receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →